Aqueous humor monocyte chemoattractant protein-1 predicted long-term visual outcome of proliferative diabetic retinopathy undergone intravitreal injection of bevacizumab and vitrectomy.

Aqueous humor monocyte chemoattractant protein-1 predicted long-term visual outcome of proliferative diabetic retinopathy undergone intravitreal injection of bevacizumab and vitrectomy.
复制标题

DOI:
10.1371/journal.pone.0248235
复制
发表时间:
2021
期刊:
影响因子:
3.7
通讯作者:
Fan X
Fan X
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Lei J;Ding G;Xie A;Hu Y;Gao N;Fan X

文献摘要

参考文献

被引文献

相似文献

We aim to investigate the risk factors associated with the prognosis of proliferative diabetic retinopathy (PDR) after a sequential treatment of intravitreal injection of bevacizumab (IVB) and pars plana vitrectomy (PPV). In this cohort study, 63 eyes from 55 patients (21 females) diagnosed with PDR, who needed PPV for non-clearing vitreous hemorrhage or fibrovascular membrane proliferation were enrolled. All the eyes underwent IVB followed by PPV. Anterior chamber tap was performed at the beginning of both procedures to evaluate the concentration of vascular endothelial growth factor (VEGF), interleukin (IL)-6, IL-8, and monocyte chemoattractant protein (MCP)-1. Forty-seven patients (54 eyes) were followed over six months, averaging 12±5 (6–19) months. The concentration of VEGF significantly decreased after IVB (P<0.001), while other cytokines did not change significantly. The aqueous humor level of IL-8 after IVB (R = 0.378, P = 0.033), MCP-1 before (R = 0.368, P = 0.021) and after (R = 0.368, P = 0.038) IVB, and combined phacoemulsification (R = 0.293, P = 0.032) was correlated with the logMAR visual acuity at the last follow-up. Multivariate analysis showed that MCP-1 was the predictor for a worse visual outcome (B = 0.108, 95% CI 0.013–0.202; P = 0.027). MCP-1 was a predictor for the unfavorable visual outcome of PDR after IVB pretreatment and PPV.
DOI: 10.1167/iovs.61.2.26
发表时间: 2020-02-01
影响因子: 4.4
作者:
Wu, Frances;Phone, Audrey;Stewart, Jay M.
通讯作者: Stewart, Jay M.
DOI: 10.1016/j.ophtha.2018.02.038
发表时间: 2018-09-01
期刊: OPHTHALMOLOGY
影响因子: 13.7
作者:
Lin, James;Chang, Jonathan S.;Smiddy, William E.
通讯作者: Smiddy, William E.
DOI: 10.1038/eye.2016.20
发表时间: 2016-05-01
期刊: EYE
影响因子: 3.9
作者:
Sassa, Y.;Yoshida, S.;Kono, T.
通讯作者: Kono, T.
DOI: 10.1016/j.jdiacomp.2017.02.017
发表时间: 2017-05-01
影响因子: 3
作者:
Reddy, Sruthi;Amutha, Anandakumar;Balasubramanyam, Muthuswamy
通讯作者: Balasubramanyam, Muthuswamy
DOI: 10.1016/j.cyto.2012.07.005
发表时间: 2012-11-01
期刊: CYTOKINE
影响因子: 3.8
作者:
Jeon, Sohee;Lee, Won Ki
通讯作者: Lee, Won Ki